Montelukast Sodium Tablet, Chewable
Product Images NDC 50090-4705

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 50090-4705). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

Line graph depicting the change in height (cm) over weeks of treatment for three groups: montelukast sodium chewable tablets (n=120), beclomethasone (n=119), and placebo (n=120). The x-axis represents weeks on treatment, ranging from 0 to 48, and the y-axis represents change in height from -3 to 7 cm, showing growth trends over time for each group.*

FDA Label Image

Camberlogo (Camberlogo)

FDA Label Image

Figure2 (Figure2)

A line graph showing mean percent change from baseline over 15 weeks in treatment for montelukast sodium versus placebo. The x-axis represents weeks in treatment, and the y-axis represents mean percent change. Two lines depict the treatment groups: one for placebo with square markers, and one for montelukast sodium with circle markers, including a washout period marked after week 12.*

FDA Label Image

Label Image (Lbl500904705)

Montelukast sodium 5 mg chewable tablets packaging label from A-S Medication Solutions. The label indicates each tablet contains 5.2 mg montelukast sodium equivalent to 5 mg montelukast. The package contains 30 chewable tablets with storage instructions to keep at 68 to 77 degrees Fahrenheit, protected from moisture and light. NDC 50090-4705-0 is displayed with lot number and manufacturer address in Libertyville, IL.*

FDA Label Image

Structure (Structure)

Chemical structure of montelukast sodium, showing the arrangement of atoms including chlorine, sulfur, and carboxylate groups, consistent with the generic drug montelukast sodium.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.